VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 3 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,212 | -88.8% | 235,927 | -70.6% | 0.00% | -100.0% |
| Q2 2023 | $19,674 | +118.5% | 802,034 | +107.3% | 0.00% | +200.0% |
| Q1 2023 | $9,005 | -7.7% | 386,945 | +0.3% | 0.00% | -50.0% |
| Q4 2022 | $9,761 | -99.9% | 385,648 | +0.0% | 0.00% | +100.0% |
| Q3 2022 | $7,436,000 | +65.4% | 385,609 | +118.4% | 0.00% | 0.0% |
| Q2 2022 | $4,496,000 | -61.2% | 176,539 | -60.8% | 0.00% | 0.0% |
| Q1 2022 | $11,583,000 | -53.7% | 450,363 | -24.6% | 0.00% | -50.0% |
| Q4 2021 | $25,015,000 | +1474.3% | 597,433 | +1536.0% | 0.00% | – |
| Q3 2021 | $1,589,000 | -55.7% | 36,519 | -51.9% | 0.00% | – |
| Q2 2021 | $3,586,000 | +12.8% | 75,853 | +22.4% | 0.00% | – |
| Q1 2021 | $3,178,000 | +81.4% | 61,979 | -5.3% | 0.00% | – |
| Q4 2020 | $1,752,000 | +93.0% | 65,416 | +147.3% | 0.00% | – |
| Q3 2020 | $908,000 | – | 26,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $40,100,000 | 21.56% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,216,644 | $571,412,000 | 2.71% |
| Nan Fung Group Holdings Ltd | 210,563 | $5,416,000 | 2.57% |
| Taikang Asset Management (Hong Kong) Co Ltd | 533,332 | $13,717,000 | 2.34% |
| Crawford Lake Capital Management, LLC | 168,200 | $4,326,000 | 1.80% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 126,900 | $3,264,000 | 1.75% |
| Zebra Capital Management LLC | 22,227 | $572,000 | 1.31% |
| Alaska Permanent Fund Corp | 2,300,000 | $59,156,000 | 0.98% |
| CLARK ESTATES INC/NY | 180,000 | $4,630,000 | 0.73% |
| Temasek Holdings (Private) Ltd | 5,602,553 | $144,097,663 | 0.61% |